Aurinia Pharmaceuticals Announces Presentations at the 2022 National Kidney Foundation Spring Clinical Meetings Pharmaceutical Investing
Resorts World Las Vegas Secures First-of-its-Kind Agreement With Allergan Aesthetics Pharmaceutical Investing
Bristol Myers Squibb Announces Data from EXPLORER-LTE Demonstrating Sustained Improvements in Clinically Meaningful Cardiovascular Outcomes at Weeks 48 and 84 in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy Receiving Mavacamten Pharmaceutical Investing
Mavacamten Demonstrated Significant Reduction in Need for Septal Reduction Therapy in Symptomatic Obstructive HCM Patients in Phase 3 VALOR Trial Pharmaceutical Investing
Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma Pharmaceutical Investing
AbbVie to Showcase Breadth of Neuroscience Portfolio and Pipeline at American Academy of Neurology 2022 Annual Meeting Pharmaceutical Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo with Chemotherapy as Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer Pharmaceutical Investing
